Ray Dalio’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.89M Buy
237,948
+27,934
+13% +$630K 0.02% 425
2025
Q4
$4.98M Buy
210,014
+159,991
+320% +$3.89M 0.02% 530
2025
Q3
$1.25M Buy
+50,023
New +$1.08M ﹤0.01% 820
2025
Q1
Sell
-12,318
Closed -$241K 769
2024
Q4
$241K Sell
12,318
-28,797
-70% -$571K ﹤0.01% 658
2024
Q3
$749K Sell
41,115
-45,829
-53% -$874K ﹤0.01% 638
2024
Q2
$1.51M Sell
86,944
-13,766
-14% -$244K 0.01% 586
2024
Q1
$1.97M Sell
100,710
-14,580
-13% -$308K 0.01% 500
2023
Q4
$2.66M Sell
115,290
-11,826
-9% -$265K 0.01% 475
2023
Q3
$2.92M Buy
127,116
+19,584
+18% +$498K 0.02% 443
2023
Q2
$2.81M Buy
107,532
+34,288
+47% +$906K 0.02% 416
2023
Q1
$2.02M Buy
73,244
+3,793
+5% +$100K 0.01% 460
2022
Q4
$1.58M Sell
69,451
-8,504
-11% -$237K 0.01% 568
2022
Q3
$2.65M Buy
77,955
+2,679
+4% +$99.1K 0.01% 499
2022
Q2
$2.19M Buy
75,276
+9,238
+14% +$235K 0.01% 666
2022
Q1
$1.76M Buy
66,038
+16,616
+34% +$392K 0.01% 710
2021
Q4
$1.28M Sell
49,422
-28,170
-36% -$702K 0.01% 527
2021
Q3
$1.83M Buy
+77,592
New +$2.71M 0.01% 445

Other funds holding PRVA

Ray Dalio's PRVA Position: Q1 2026 in Review

Ray Dalio increased its Privia Health (PRVA) stake by 13% in Q1 2026, buying an estimated $630K and bringing the position to 237,948 shares worth $4.89M. The position accounts for 0.02% of the portfolio, ranked #425.

Ray Dalio first reported a position in PRVA in Q3 2021 and has held it in 17 quarters since. The position peaked at $4.98M in Q4 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Ray Dalio held 237,948 shares of Privia Health worth $4.89M as of Q1 2026.
  • Ray Dalio bought 27,934 Privia Health shares in Q1 2026, an estimated $630K.
  • Privia Health made up 0.02% of Ray Dalio's portfolio in Q1 2026, its #425 holding.
  • Ray Dalio first reported a position in Privia Health in Q3 2021 and has held it in 17 quarters since.
  • Ray Dalio's Privia Health position peaked at $4.98M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.